356 related articles for article (PubMed ID: 19461882)
1. Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase.
Narvaiza I; Linfesty DC; Greener BN; Hakata Y; Pintel DJ; Logue E; Landau NR; Weitzman MD
PLoS Pathog; 2009 May; 5(5):e1000439. PubMed ID: 19461882
[TBL] [Abstract][Full Text] [Related]
2. Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities.
Bulliard Y; Narvaiza I; Bertero A; Peddi S; Röhrig UF; Ortiz M; Zoete V; Castro-Díaz N; Turelli P; Telenti A; Michielin O; Weitzman MD; Trono D
J Virol; 2011 Feb; 85(4):1765-76. PubMed ID: 21123384
[TBL] [Abstract][Full Text] [Related]
3. Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms.
Thielen BK; McNevin JP; McElrath MJ; Hunt BV; Klein KC; Lingappa JR
J Biol Chem; 2010 Sep; 285(36):27753-66. PubMed ID: 20615867
[TBL] [Abstract][Full Text] [Related]
4. Functional domain organization of human APOBEC3G.
Gooch BD; Cullen BR
Virology; 2008 Sep; 379(1):118-24. PubMed ID: 18639915
[TBL] [Abstract][Full Text] [Related]
5. A DNA sequence recognition loop on APOBEC3A controls substrate specificity.
Logue EC; Bloch N; Dhuey E; Zhang R; Cao P; Herate C; Chauveau L; Hubbard SR; Landau NR
PLoS One; 2014; 9(5):e97062. PubMed ID: 24827831
[TBL] [Abstract][Full Text] [Related]
6. Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity.
Goila-Gaur R; Khan MA; Miyagi E; Kao S; Strebel K
Retrovirology; 2007 Aug; 4():61. PubMed ID: 17727729
[TBL] [Abstract][Full Text] [Related]
7. APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons.
Chen H; Lilley CE; Yu Q; Lee DV; Chou J; Narvaiza I; Landau NR; Weitzman MD
Curr Biol; 2006 Mar; 16(5):480-5. PubMed ID: 16527742
[TBL] [Abstract][Full Text] [Related]
8. Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains.
Hakata Y; Landau NR
J Biol Chem; 2006 Dec; 281(48):36624-31. PubMed ID: 17020885
[TBL] [Abstract][Full Text] [Related]
9. Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G.
Henry M; Guétard D; Suspène R; Rusniok C; Wain-Hobson S; Vartanian JP
PLoS One; 2009; 4(1):e4277. PubMed ID: 19169351
[TBL] [Abstract][Full Text] [Related]
10. Evolution of the primate APOBEC3A cytidine deaminase gene and identification of related coding regions.
Henry M; Terzian C; Peeters M; Wain-Hobson S; Vartanian JP
PLoS One; 2012; 7(1):e30036. PubMed ID: 22272271
[TBL] [Abstract][Full Text] [Related]
11. Different modes of retrovirus restriction by human APOBEC3A and APOBEC3G in vivo.
Stavrou S; Crawford D; Blouch K; Browne EP; Kohli RM; Ross SR
PLoS Pathog; 2014 May; 10(5):e1004145. PubMed ID: 24851906
[TBL] [Abstract][Full Text] [Related]
12. Structural determinants of human APOBEC3A enzymatic and nucleic acid binding properties.
Mitra M; Hercík K; Byeon IJ; Ahn J; Hill S; Hinchee-Rodriguez K; Singer D; Byeon CH; Charlton LM; Nam G; Heidecker G; Gronenborn AM; Levin JG
Nucleic Acids Res; 2014 Jan; 42(2):1095-110. PubMed ID: 24163103
[TBL] [Abstract][Full Text] [Related]
13. The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains.
Bogerd HP; Wiegand HL; Doehle BP; Cullen BR
Virology; 2007 Aug; 364(2):486-93. PubMed ID: 17434555
[TBL] [Abstract][Full Text] [Related]
14. Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity.
Pautasso S; Galitska G; Dell'Oste V; Biolatti M; Cagliani R; Forni D; De Andrea M; Gariglio M; Sironi M; Landolfo S
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045985
[TBL] [Abstract][Full Text] [Related]
15. A chimeric human APOBEC3A protein with a three amino acid insertion confers differential HIV-1 and adeno-associated virus restriction.
Wang Y; Wang Z; Pramanik A; Santiago ML; Qiu J; Stephens EB
Virology; 2016 Nov; 498():149-163. PubMed ID: 27584592
[TBL] [Abstract][Full Text] [Related]
16. Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.
Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander R; Patterson AP
J Biol Chem; 2017 Aug; 292(32):13459-13479. PubMed ID: 28637869
[TBL] [Abstract][Full Text] [Related]
17. Interaction with the CCT chaperonin complex limits APOBEC3A cytidine deaminase cytotoxicity.
Green AM; DeWeerd RA; O'Leary DR; Hansen AR; Hayer KE; Kulej K; Dineen AS; Szeto JH; Garcia BA; Weitzman MD
EMBO Rep; 2021 Sep; 22(9):e52145. PubMed ID: 34347354
[TBL] [Abstract][Full Text] [Related]
18. APOBEC3A is a prominent cytidine deaminase in breast cancer.
Cortez LM; Brown AL; Dennis MA; Collins CD; Brown AJ; Mitchell D; Mertz TM; Roberts SA
PLoS Genet; 2019 Dec; 15(12):e1008545. PubMed ID: 31841499
[TBL] [Abstract][Full Text] [Related]
19. Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association.
Niewiadomska AM; Tian C; Tan L; Wang T; Sarkis PT; Yu XF
J Virol; 2007 Sep; 81(17):9577-83. PubMed ID: 17582006
[TBL] [Abstract][Full Text] [Related]
20. APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1.
Ooms M; Krikoni A; Kress AK; Simon V; Münk C
J Virol; 2012 Jun; 86(11):6097-108. PubMed ID: 22457529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]